Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy.
about
Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis.Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study
P2860
Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Molecular Marker Expression Is ...... sponse to Neoadjuvant Therapy.
@en
Molecular Marker Expression Is ...... sponse to Neoadjuvant Therapy.
@nl
type
label
Molecular Marker Expression Is ...... sponse to Neoadjuvant Therapy.
@en
Molecular Marker Expression Is ...... sponse to Neoadjuvant Therapy.
@nl
prefLabel
Molecular Marker Expression Is ...... sponse to Neoadjuvant Therapy.
@en
Molecular Marker Expression Is ...... sponse to Neoadjuvant Therapy.
@nl
P2093
P2860
P1476
Molecular Marker Expression Is ...... esponse to Neoadjuvant Therapy
@en
P2093
Brian S Diggs
Gene Bakis
James P Dolan
John G Hunter
Kenneth M Gatter
Nathan W Bronson
P2860
P2888
P304
P356
10.1007/S11605-015-2944-7
P577
2015-09-22T00:00:00Z